ArticleClinical cancer research : an official journal of the American Association for Cancer Research2024

Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor-Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer.

Komal L Jhaveri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.